We are international
Donate
TEXT SIZE   


Dr. Niesvizky - A Phase I Study of PD 0332991: Complete CDK4/6 Inhibition and Tumor Response In Sequential Combination with Bortezomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
Ruben Niesvizky, MD
Weill Cornell Medical College
New York, New York
USA
12.02.10


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.


 related articles